ORTIN GLOBAL balance sheet

·Pharma & HealthChart ›
As of Mar 2026
Total assets
₹4.6cr+22.9% on Mar 2025
Shareholders' equity
₹1.2cr−37.4% on Mar 2025
Total debt
₹1.0cr+302.0% on Mar 2025
Cash and investments
₹0.6cr+62.1% on Mar 2025
₹ crore except per share
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Non-current assets
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.00.00.014.0
0.0——0.4
0.8—0.20.3
0.80.00.20.3
0.00.1—0.0
0.80.10.214.7
Current assets
0.00.00.12.6
0.20.31.83.4
0.60.40.50.2
0.00.01.90.0
—0.4—0.0
0.81.04.13.7
3.02.72.20.3
3.83.76.36.5
4.63.86.621.2
Equity
8.18.18.18.1
−6.9−6.2−5.32.7
1.22.02.810.9
1.22.02.810.9
Liabilities
1.00.31.83.0
1.00.31.83.0
0.00.00.00.1
——−0.10.3
1.00.31.73.4
0.00.00.03.5
0.00.00.11.5
—1.5—0.0
0.01.60.15.0
0.00.00.00.1
——0.20.0
2.4—1.81.8
2.41.62.07.0
3.41.83.810.3
4.63.86.621.2
Trade payables — MSME split
0.00.0——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

ORTINGLOBE₹12.41

ORTIN GLOBAL LIMITED

· Pharma & Health
₹ CrorePeersLASAMANGALAMBIOFILCHEMVINEETLABKREBSBIOALPABALPHARMANATCAPSUQMcap ₹10.1 Cr
View
In ₹ Crore except Per Share
As of
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment14.00.00.00.00.0
+ Capital Work-in-Progress0.4——0.00.0
+ Other Non-current Financial Assets0.30.2—0.80.8
Non-current Financial Assets0.30.20.00.80.8
+ Deferred Tax Assets0.0—0.10.00.0
Total Non-current Assets14.70.20.10.80.8
Current Assets
+ Inventories2.60.10.00.00.0
+ Trade Receivables3.41.80.30.20.2
+ Cash & Cash Equivalents0.20.50.40.60.6
+ Other Bank Balances0.01.90.00.00.0
+ Other Current Financial Assets0.0—0.4——
Current Financial Assets3.74.11.00.80.8
+ Other Current Assets0.32.22.73.03.0
Total Current Assets6.56.33.73.83.8
Total Assets21.26.63.84.64.6
Equity
+ Equity Share Capital8.18.18.18.18.1
+ Other Equity / Reserves2.7-5.3-6.2-6.9-6.9
Equity — Owners of Parent10.92.82.01.21.2
Total Equity10.92.82.01.21.2
Liabilities
+ Borrowings — Non-current3.01.80.31.01.0
Non-current Financial Liabilities3.01.80.31.01.0
+ Provisions — Non-current0.10.00.00.00.0
+ Deferred Tax Liabilities0.3-0.1———
Non-current Liabilities3.41.70.31.01.0
+ Borrowings — Current3.50.00.00.00.0
+ Trade Payables1.50.10.00.00.0
+ Other Current Financial Liab0.0—1.5——
Current Financial Liabilities5.00.11.60.00.0
+ Provisions — Current0.10.00.00.00.0
+ Current Tax Liabilities0.00.2———
+ Other Current Liabilities1.81.8—2.42.4
Current Liabilities7.02.01.62.42.4
Total Liabilities10.33.81.83.43.4
Total Equity & Liabilities21.26.63.84.64.6
Trade Payables — MSME split
+ Dues to Other Creditors — Current——0.00.00.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.